title: Prevalence of urinary tract infection during outpatient follow-up after renal transplantation.
abstract: Seven hundred and twenty-seven renal transplant patients are reviewed with respect to the occurrence of urinary tract infection (UTI) after renal transplantation. UTI was defined as the detection of both bacteriuria (10(5) CFU/ml) and pyuria (10 leukocytes/hpf). UTI developed in 11 of the inpatients (20.8%) and in 30 (4.2%) of the outpatients during a one-year period. Among outpatients, 12 had symptomatic infections, comprising seven with acute pyelonephritis and five with acute cystitis. Asymptomatic UTI was detected in 18 patients. In addition, asymptomatic bacteriuria without pyuria was observed in ten (1.4%) patients. UTI was more common in patients with diabetes, and underlying urinary tract complications were present in some patients. Administration of trimethoprim-sulfamethoxazole for about 4 months is suggested to reduce the frequency of UTI in the early period after renal transplantation.
authors.affiliation: Dept. of Urology, Tokyo Women's Medical College, Shinjuku-ku, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Goya
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: Y
authors.initials: Y
authors.lastname: Iguchi
authors.forename: T
authors.initials: T
authors.lastname: Oshima
authors.forename: T
authors.initials: T
authors.lastname: Yagisawa
authors.forename: H
authors.initials: H
authors.lastname: Toma
authors.forename: T
authors.initials: T
authors.lastname: Agishi
authors.forename: K
authors.initials: K
authors.lastname: Ota
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000382:microbiology; D001437:Bacteriuria / Q000175:diagnosis; D002176:Candida albicans / Q000302:isolation & purification; D015169:Colony Count, Microbial; D003556:Cystitis / Q000175:diagnosis / Q000382:microbiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000502:physiology; D007681:Kidney Papillary Necrosis / Q000175:diagnosis / Q000382:microbiology; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D009181:Mycoses / Q000175:diagnosis / Q000453:epidemiology* / Q000382:microbiology; D011776:Pyuria / Q000175:diagnosis; D013997:Time Factors; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents